Login
IQVIA Holdings Inc logo

IQVIA Holdings Inc

ir.iqvia.com

IQVIA Holdings Inc (NYSE: IQV) is a life sciences data, technology, and contract research organization that provides data analytics, clinical research, and commercial services to the pharmaceutical, biotechnology, and medical device industries. It generates revenue through long-term service contracts covering clinical trial management, real-world evidence, technology platforms, and healthcare data subscriptions. The 10-K filed 2026-02-17 (accession 000162828026008322) for the fiscal year ended discloses that most contracts may be terminated on short notice, indicating a mix of multi-year engagements and shorter-term arrangements. IQVIA's moat derives from proprietary healthcare data assets and switching costs embedded in clinical and commercial outsourcing relationships. The company cautions that data suppliers could restrict access or refuse to license data, which underscores how central third-party data sourcing is to its business model. Operations span international markets, with exposure to currency fluctuation and geopolitical risk noted as material factors.

Products & Services

Clinical trial management and contract research services, real-world evidence analytics, healthcare data and technology platforms, and commercial outsourcing services for life sciences clients.

Revenue Model

Service contracts covering clinical research outsourcing, healthcare data subscriptions, and technology platform access. Contracts are primarily fee-for-service or subscription arrangements; most can be terminated on short notice per the FY2025 10-K filing.

Customers & Markets

Pharmaceutical, biotechnology, and medical device companies. The filing notes risk from loss or delay of large client contracts and an inability to enter new contracts, indicating meaningful client concentration risk, though specific customer concentration percentages are not supported by the excerpts.

Geographic Exposure

International operations with exposure to currency risk and international conflict noted as material business disruption factors. Specific country or regional revenue splits are not supported by the filing excerpts provided.

Financial Snapshot

Revenue
TTM
$16.63B
Gross Margin
TTM
33.0%
Net Income
TTM
$1.385B
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
74.68%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$6.349B
Cash
2026 Q1
P/E
TTM
25.05
Free Cash Flow
TTM
$2.116B

Stock Price

Loading...
Market Cap: $34.69 Billion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support